Hanover Bancorp, Inc. filings document the regulatory record of a Maryland bank holding company and its Hanover Community Bank subsidiary. Recent 8-Ks furnish quarterly and annual operating results, investor presentations under Regulation FD, management and compensation matters, and material agreements related to fixed-to-floating subordinated notes due 2036.
Proxy materials describe annual meeting votes, director elections, equity incentive plan approval, auditor ratification, board governance, executive compensation, and shareholder voting procedures.
Hanover Bancorp, Inc. reported that its Senior Executive Vice President and Chief Financial Officer, Lance P. Burke, received an equity grant in the form of restricted common stock. He was awarded 3,185 shares on February 5, 2026, at a price of $0.0000 per share, increasing his directly held beneficial ownership to 29,142 common shares.
The grant is structured to vest over three years, with one-third of the shares vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029, and is subject to forfeiture conditions typically tied to continued service or performance.
Hanover Bancorp executive Kevin Corbett reported an equity grant of company stock. As EVP & Chief Credit Officer, he received 2,198 shares of Hanover Bancorp common stock on February 5, 2026 at a price of $0.0000 per share, reflecting a restricted stock award rather than an open-market purchase.
These shares are subject to forfeiture and will vest over three years, with one-third scheduled to vest on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. Following this grant, Corbett directly holds 29,123 shares of Hanover Bancorp common stock.
Hanover Bancorp, Inc. director Ahron H. Haspel received a grant of 1,592 shares of common stock on February 5, 2026. The shares were granted at a price of $0.0000 per share as restricted stock subject to forfeiture.
The restricted stock vests over three years, with one-third vesting on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. After this award, Haspel directly beneficially owned 29,035 common shares and indirectly beneficially owned 39,673 common shares through an LLC.
Hanover Bancorp, Inc. director Metin Negrin received a grant of 1,592 shares of common stock on February 5, 2026. The grant is in the form of restricted stock subject to forfeiture.
The restricted shares vest over three years, with one-third vesting on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. Following this award, Negrin directly beneficially owns 238,647 shares of Hanover Bancorp common stock.
Hanover Bancorp, Inc. reported that Chairman and CEO Michael P. Puorro received a grant of 10,945 shares of restricted common stock on February 5, 2026 at a price of $0.0000 per share. These shares are subject to forfeiture and vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. After this award, Puorro directly beneficially owns 326,046 shares of Hanover Bancorp common stock.
Hanover Bancorp, Inc. reported that officer Lisa A. DiIorio, FSVP & Chief Accounting Officer, received a grant of 1,062 shares of common stock on February 5, 2026 at a price of $0.0000 per share. This restricted stock award is subject to forfeiture and will vest in three equal installments, with one-third vesting on March 1, 2027, one-third on March 1, 2028, and one-third on March 1, 2029. Following this grant, she beneficially owns 16,365 shares of Hanover Bancorp common stock, held directly.
Hanover Bancorp, Inc. filed a current report to announce that it has released its financial results for the three months and year ended December 31, 2025. The company issued a press release on January 29, 2026 summarizing these results.
The press release is furnished as Exhibit 99.1 to this report and is not treated as filed for liability purposes under securities laws. The filing is signed by Executive Vice President and Chief Financial Officer Lance P. Burke as the company’s principal financial officer.
Hanover Bancorp, Inc. furnished an investor presentation under Item 7.01 (Regulation FD) via an 8‑K. The presentation is attached as Exhibit 99.1 and is incorporated by reference in this report. The company notes the materials are being furnished, not filed under the Exchange Act, and therefore are not automatically incorporated into any Securities Act registration statement unless expressly identified there.
The event date is November 11, 2025. Hanover’s common stock trades on NASDAQ under the symbol HNVR. The report was signed by Executive Vice President and Chief Financial Officer Lance P. Burke.
Hanover Bancorp, Inc. (HNVR) reported Q3 2025 results. Net income was $3,491 versus $3,539 a year ago, with basic and diluted EPS of $0.47 versus $0.48. Net interest income rose to $15,223 from $13,102 as interest expense declined to $17,771 from $21,011. The provision for credit losses increased to $1,325 from $200. Non‑interest income was $2,785 versus $3,954, including a gain on sale of loans held‑for‑sale of $1,451 versus $2,834. Total non‑interest expense was $12,013 versus $12,238; earlier in 2025 the company recorded approximately $3,200 of one‑time core conversion costs.
For the nine months, net income was $7,455 versus $8,444. The balance sheet expanded modestly: total assets were $2,331,580 versus $2,312,110 at December 31, 2024. Deposits were $1,974,823 versus $1,954,283, and loans, net, were $1,966,329 versus $1,962,745. Accumulated other comprehensive loss improved to $(778) from $(1,334). Securities available‑for‑sale were $100,037. Common shares outstanding were 7,192,390 as of October 31, 2025.
Hanover Bancorp (HNVR) director reported an open-market sale of 5,000 shares of common stock on 11/04/2025 at $21.2495 per share.
Following the transaction, reported beneficial ownership includes 24,676 shares held directly and multiple indirect positions. Examples include 80,769 shares held in various trusts for a sibling (trustee role noted), 196,558 shares held in trusts for the reporting person (spouse as trustee), and stakes via entities and family trusts as detailed in the footnotes.